245 related articles for article (PubMed ID: 33037200)
1. Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice.
van den Bemt L; van den Nieuwenhof L; Rutjes A; van der Meer V; Stege G; Wensing M; Teichert M; Schermer T
NPJ Prim Care Respir Med; 2020 Oct; 30(1):43. PubMed ID: 33037200
[TBL] [Abstract][Full Text] [Related]
2. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
Vogelmeier C; Worth H; Buhl R; Criée CP; Lossi NS; Mailänder C; Kardos P
Int J Chron Obstruct Pulmon Dis; 2017; 12():487-494. PubMed ID: 28203072
[TBL] [Abstract][Full Text] [Related]
3. Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice.
Kaplan AG
Int J Chron Obstruct Pulmon Dis; 2015; 10():2535-48. PubMed ID: 26648711
[TBL] [Abstract][Full Text] [Related]
4. Withdrawal of Inhaled Corticosteroids from Patients with COPD; Effect on Exacerbation Frequency and Lung Function: A Systematic Review.
Georgiou A; Ramesh R; Schofield P; White P; Harries TH
Int J Chron Obstruct Pulmon Dis; 2024; 19():1403-1419. PubMed ID: 38919905
[TBL] [Abstract][Full Text] [Related]
5. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
Watz H; Tetzlaff K; Wouters EF; Kirsten A; Magnussen H; Rodriguez-Roisin R; Vogelmeier C; Fabbri LM; Chanez P; Dahl R; Disse B; Finnigan H; Calverley PM
Lancet Respir Med; 2016 May; 4(5):390-8. PubMed ID: 27066739
[TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
Yang IA; Fong KM; Sim EH; Black PN; Lasserson TJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD002991. PubMed ID: 17443520
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO).
Rossi A; Guerriero M; Corrado A;
Respir Res; 2014 Jul; 15(1):77. PubMed ID: 25005873
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study.
Magnussen H; Lucas S; Lapperre T; Quint JK; Dandurand RJ; Roche N; Papi A; Price D; Miravitlles M;
Respir Res; 2021 Jan; 22(1):25. PubMed ID: 33478491
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial.
Choudhury AB; Dawson CM; Kilvington HE; Eldridge S; James WY; Wedzicha JA; Feder GS; Griffiths CJ
Respir Res; 2007 Dec; 8(1):93. PubMed ID: 18162137
[TBL] [Abstract][Full Text] [Related]
10. Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.
Lee SH; Lee JH; Yoon HI; Park HY; Kim TH; Yoo KH; Oh YM; Jung KS; Lee SD; Lee SW
Respir Res; 2019 Mar; 20(1):62. PubMed ID: 30922302
[TBL] [Abstract][Full Text] [Related]
11. A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.
Miravitlles M; Cosío BG; Arnedillo A; Calle M; Alcázar-Navarrete B; González C; Esteban C; Trigueros JA; Rodríguez González-Moro JM; Quintano Jiménez JA; Baloira A
Respir Res; 2017 Nov; 18(1):198. PubMed ID: 29183382
[TBL] [Abstract][Full Text] [Related]
12. Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice.
Cataldo D; Derom E; Liistro G; Marchand E; Ninane V; Peché R; Slabbynck H; Vincken W; Janssens W
Int J Chron Obstruct Pulmon Dis; 2018; 13():2089-2099. PubMed ID: 30013336
[TBL] [Abstract][Full Text] [Related]
13. Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale.
Magnussen H; Watz H; Kirsten A; Decramer M; Dahl R; Calverley PM; Towse L; Finnigan H; Tetzlaff K; Disse B
Respir Med; 2014 Apr; 108(4):593-9. PubMed ID: 24477080
[TBL] [Abstract][Full Text] [Related]
14. Inhaled Corticosteroid Withdrawal and Change in Lung Function in Primary Care Patients with Chronic Obstructive Pulmonary Disease in England.
Whittaker HR; Wing K; Douglas I; Kiddle SJ; Quint JK
Ann Am Thorac Soc; 2022 Nov; 19(11):1834-1841. PubMed ID: 35767034
[No Abstract] [Full Text] [Related]
15. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
16. Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
Kunz LI; Ten Hacken NH; Lapperre TS; Timens W; Kerstjens HA; van Schadewijk A; Vonk JM; Sont JK; Snoeck-Stroband JB; Postma DS; Sterk PJ; Hiemstra PS;
Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28049170
[TBL] [Abstract][Full Text] [Related]
17. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.
Rodrigo GJ; Price D; Anzueto A; Singh D; Altman P; Bader G; Patalano F; Fogel R; Kostikas K
Int J Chron Obstruct Pulmon Dis; 2017; 12():907-922. PubMed ID: 28360514
[TBL] [Abstract][Full Text] [Related]
18. Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline.
Ferguson GT; Shaikh A; Tetzlaff K; Mueller A; Magnussen H; Watz H
Int J Chron Obstruct Pulmon Dis; 2020; 15():2879-2888. PubMed ID: 33204084
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
[TBL] [Abstract][Full Text] [Related]
20. Switching from long-acting beta-agonist and inhaled corticosteroid to long-acting beta-agonist and long-acting muscarinic antagonist for chronic obstructive pulmonary disease: a case report of inhaled corticosteroid withdrawal.
Lam JCM
Intern Med J; 2020 Sep; 50 Suppl 3():15-18. PubMed ID: 32985094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
